Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MRCP (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Consultant Physician
MBBS, MRCP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology), M.R.C.P (U.K), M.A.C.G (USA)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology), M.R.C.P (U.K), M.A.C.G (USA)
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures